Media Pack
News

Current Edition

Volume 6 Issue 3

Upcoming Events

Advertisement

 
 
news

Bristol Myers returns to Immatics for a dual-targeting cancer drug

Bristol Myers' acquisition of Celgene immediately made the big pharma a top player in the development of cancer cell therapies. Since the deal closed, Bristol Myers h...
15 December 2021 news Breyanzi | Bristol Myers
Continue Reading →
news

Pfizer stocks cancer drug pipeline with $2.3B deal for Trillium

Pfizer is building up its pipeline of experimental cancer medicines, announcing Monday a deal to buy the Cambridge, Massachusetts-based biotech Trillium Therapeutics ...
27 August 2021 news Biotech | cancer drug
Continue Reading →
news

Merck wins approval for cancer drug acquired in 2019 biotech buyout

Peloton was one of a handful of cancer-focused biotech companies acquired since 2018 by Merck, which has sought to complement its top-selling immunotherapy Keytruda w...
20 August 2021 news ArQule | Biotech
Continue Reading →
news

GSK, in race to catch up with rivals, wins expanded approval for cancer drug

GSK has high hopes for Jemperli as it transitions to what's being called the "new GSK," with a greater focus on experimental drugs for infectious disease, cancer and ...
20 August 2021 news Bristol Myers Squibb | cancer
Continue Reading →
news

Amgen, expecting higher demand for its medicines, to build plant in North Carolina

Facing increased competition for many of its top-selling drugs, Amgen is focusing on building its pipeline of drugs for the future, especially in the areas of oncolog...
5 August 2021 news Amgen | cancer drug
Continue Reading →
 
 
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2023, All Rights Reserved – Powered by Teksyte